1 2655 113 YOGA IMPROVES QUALITY OF LIFE AND FALL RISK-FACTORS IN A SAMPLE OF PEOPLE WITH CHRONIC PAIN AND TYPE 2 DIABETES. OBJECTIVE: ASSESS PRE TO-POST OUTCOMES FOR PEOPLE WITH CHRONIC PAIN AND TYPE 2 DIABETES MELLITUS (T2DM) RANDOMIZED TO AN 8-WEEK YOGA INTERVENTION OR USUAL CARE. METHODS: PARTICIPANTS WERE INCLUDED IF THEY SELF-REPORTED: CHRONIC PAIN; T2DM; >18 YEARS OLD; NO EXERCISE RESTRICTIONS OR CONSISTENT YOGA; AND CONSENTED TO THE STUDY. RESULTS: AFTER YOGA, THERE WERE SIGNIFICANT IMPROVEMENTS IN: BRIEF PAIN INVENTORY PAIN INTERFERENCE (49+/-15.00 VS. 41.25+/-19.46, P=.034); FULLERTON ADVANCED BALANCE SCALE (14.2+/-14.1 VS. 20.4+/-13.5, P=.03); UPPER EXTREMITY STRENGTH (7.7+/-6.3 VS.10.8+/-6.5, P=.02); LOWER EXTREMITY STRENGTH (4.1+/-3.8 VS. 6.7+/-4.8, P=.02); AND RAND 36-ITEM HEALTH SURVEY QUALITY OF LIFE SCORES (81.1+/-7.7 VS. 91.9+/-8.9, P=.04). BALANCE SCORES BECAME SIGNIFICANTLY WORSE DURING THE 8 WEEKS FOR PEOPLE RANDOMIZED TO THE CONTROL (27.1+/-9.9 VS. 21.7+/-13.4,=P.01). CONCLUSION: DATA FROM THIS SMALL RCT INDICATES YOGA MAY BE THERAPEUTIC AND MAY IMPROVE MULTIPLE OUTCOMES IN THIS SEEMINGLY AT-RISK POPULATION. CLINICAL TRIALS NUMBER: NCT03010878. 2018 2 2164 26 THE EFFECTS OF YOGA AND SELF-ESTEEM ON MENOPAUSAL SYMPTOMS AND QUALITY OF LIFE IN BREAST CANCER SURVIVORS-A SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: PREVIOUS RESEARCH HAS FOUND THAT YOGA CAN ENHANCE QUALITY OF LIFE AND EASE MENOPAUSAL SYMPTOMS OF BREAST CANCER SURVIVORS. THE STUDY EXAMINED WHETHER SELF-ESTEEM MEDIATED THE EFFECTS OF YOGA ON QUALITY OF LIFE, FATIGUE AND MENOPAUSAL SYMPTOMS, UTILIZING VALIDATED OUTCOME MEASURES. STUDY DESIGN: THIS IS A SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL COMPARING THE EFFECTS OF YOGA WITH THOSE OF USUAL CARE IN 40 BREAST CANCER SURVIVORS WHO SUFFERED FROM MENOPAUSAL SYMPTOMS. ALL PARTICIPANTS COMPLETED ALL 3 ASSESSMENTS (WEEK 0, WEEK 12, AND WEEK 24) AND PROVIDED FULL DATA. MAIN OUTCOME MEASURES: OUTCOMES WERE MEASURED USING SELF-RATING INSTRUMENTS. MEDIATION ANALYSES WERE PERFORMED USING SPSS. RESULTS: SELF-ESTEEM MEDIATED THE EFFECT OF YOGA ON TOTAL MENOPAUSAL SYMPTOMS (B=-2.11, 95% BCI [-5.40 TO -0.37]), PSYCHOLOGICAL MENOPAUSAL SYMPTOMS (B=-0.94, 95% BCI [-2.30 TO -0.01]), AND UROGENITAL MENOPAUSAL SYMPTOMS (B=-0.66, 95% BCI [-1.65 TO -0.15]), QUALITY OF LIFE (B=8.04, 95% BCI [3.15-17.03]), SOCIAL WELL-BEING (B=1.80, 95% BCI [0.54-4.21]), EMOTIONAL WELL-BEING (B=1.62, 95% BCI [0.70-3.34]), FUNCTIONAL WELL-BEING (B=1.84, 95% BCI [0.59-4.13]), AND FATIGUE (B=4.34, 95% BCI [1.28-9.55]). SELF-ESTEEM HAD NO EFFECT ON SOMATOVEGETATIVE MENOPAUSAL SYMPTOMS (B=-0.50, 95% BCI N.S.) OR ON PHYSICAL WELL-BEING (B=0.79, 95% BCI N.S.). CONCLUSIONS: FINDINGS SUPPORT THE ASSUMPTION THAT SELF-ESTEEM PLAYS A VITAL ROLE IN THE BENEFICIAL EFFECT OF YOGA AND THAT YOGA CAN HAVE LONG-TERM BENEFITS FOR WOMEN DIAGNOSED WITH BREAST CANCER AND UNDERGOING MENOPAUSAL TRANSITION. 2017 3 1432 27 IMPROVING PHYSICAL AND MENTAL HEALTH IN FRONTLINE MENTAL HEALTH CARE PROVIDERS: YOGA-BASED STRESS MANAGEMENT VERSUS COGNITIVE BEHAVIORAL STRESS MANAGEMENT. THE NEED FOR BRIEF, LOW-COST, EASILY DISSEMINABLE AND EFFECTIVE INTERVENTIONS TO PROMOTE HEALTHY LIFESTYLES IS HIGH. THIS IS ESPECIALLY TRUE FOR MENTAL HEALTH PROVIDERS. WE DEVELOPED TWO STUDIES TO COMPARE THE IMPACTS OF COGNITIVE BEHAVIORAL STRESS MANAGEMENT (CBSM) AND YOGA BASED STRESS MANAGEMENT (YBSM) INTERVENTIONS FOR HEALTHCARE PROFESSIONALS. STUDY 1 OFFERED AN 8-WEEK YBSM INTERVENTION TO 37 MENTAL HEALTHCARE PARTICIPANTS AND COLLECTED HEALTH DATA PRE AND POST. STUDY 2 OFFERED YBSM AND CBSM CLASSES TO 40 RANDOMLY ASSIGNED MENTAL HEALTHCARE PROVIDERS AND COLLECTED MENTAL AND PHYSICAL HEALTH DATA AT FOUR TIME POINTS. IN STUDY 1, USING T-TESTS, THE YBSM INTERVENTION AFFECTED A NUMBER OF MENTAL AND PHYSICAL WELLBEING INDICES PRE TO POST. IN STUDY 2, USING LINEAR MIXED MODELING, BOTH YBSM AND CBSM GROUPS IMPROVED SIGNIFICANTLY (P <.05) IN FRUIT AND VEGETABLE INTAKE, HEART RATE, ALCOHOL CONSUMPTION, RELAXATION AND AWARENESS, PROFESSIONAL QUALITY OF LIFE, COMPASSION SATISFACTION, BURNOUT, DEPRESSION, AND STRESS LEVELS. THERE WAS A GROUP BY TIME EFFECT FOR COPING CONFIDENCE (CBSM INCREASED MORE, P<.05, F = 4.34), PHYSICAL ACTIVITY (YBSM INCREASED MORE, P<.05, F = 3.47), OVERALL MENTAL HEALTH (YBSM INCREASED MORE, P<.10, F =5.32), AND SECONDARY TRAUMATIC STRESS (YBSM DECREASED MORE, P<.10, F = 4.89). YBSM AND CBSM APPEAR TO BE USEFUL FOR HEALTHCARE PROFESSIONALS' MENTAL AND PHYSICAL HEALTH. YBSM DEMONSTRATES SOME BENEFIT ABOVE AND BEYOND THE EXTREMELY WELL-STUDIED AND EMPIRICALLY SUPPORTED CBSM, INCLUDING INCREASED PHYSICAL ACTIVITY, OVERALL MENTAL HEALTH, AND DECREASED SECONDARY TRAUMATIC STRESS BENEFITS. 2017 4 1019 30 EFFECTS OF WEEKLY ONE-HOUR HATHA YOGA THERAPY ON RESILIENCE AND STRESS LEVELS IN PATIENTS WITH SCHIZOPHRENIA-SPECTRUM DISORDERS: AN EIGHT-WEEK RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: TO EXAMINE THE EFFECTS OF HATHA YOGA THERAPY ON RESILIENCE, BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) LEVELS, AND SALIVARY ALPHA AMYLASE (SAA) ACTIVITY IN PATIENTS WITH SCHIZOPHRENIA-SPECTRUM DISORDERS. DESIGN AND PARTICIPANTS: SINGLE-BLINDED, RANDOMIZED CONTROLLED STUDY IN WHICH OUTPATIENTS WITH SCHIZOPHRENIA OR RELATED PSYCHOTIC DISORDERS (ACCORDING TO INTERNATIONAL CLASSIFICATION OF DISEASES, 10TH REVISION) WERE RANDOMLY ASSIGNED TO A YOGA OR A CONTROL GROUP. SETTING: NOVEMBER 2012-APRIL 2013 AT YAMANASHI PREFECTURAL KITA HOSPITAL, JAPAN. INTERVENTIONS: IN THE YOGA GROUP, PATIENTS RECEIVED WEEKLY 1-HOUR HATHA YOGA SESSIONS, IN ADDITION TO REGULAR TREATMENT, FOR 8 WEEKS. THOSE IN THE CONTROL GROUP UNDERWENT REGULAR TREATMENT, WHICH INCLUDED A DAYCARE REHABILITATION PROGRAM. OUTCOME MEASURES: ASSESSMENTS INCLUDED THE 25-ITEM RESILIENCE SCALE (RS), POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS), PLASMA AND SALIVARY BDNF LEVEL, AND SAA ACTIVITY. RESULTS: FIFTY PATIENTS PARTICIPATED (25 IN EACH GROUP; MEAN AGE+/-STANDARD DEVIATION, 50.9+/-11.3 YEARS; MEAN DURATION OF ILLNESS, 25.0+/-10.3 YEARS; MEAN TOTAL PANSS SCORE, 78.2+/-17.3). NO SIGNIFICANT DIFFERENCES IN CHANGES IN ANY VARIABLE FROM BASELINE TO WEEK 8 WERE FOUND BETWEEN THE TWO GROUPS (CHANGES IN THE YOGA GROUP VERSUS THE CONTROL GROUP: RS SCORE, -1.6+/-19.9 VERSUS 0.3+/-17.2; PANSS SCORE, 0.5+/-12.0 VERSUS 5.0+/-15.6; PLASMA BDNF, 41.6+/-377.0 PG/DL VERSUS 73.4+/-346.0 PG/DL; SAA, -26.2+/-72.6 KU/L VERSUS -13.8+/-68.0 KU/L, RESPECTIVELY). CONCLUSIONS: ADJUNCT YOGA THERAPY SHOWED NO POSITIVE CHANGES IN RESILIENCE LEVEL OR STRESS MARKERS. DURATION AND INTENSITY OF YOGA SESSIONS AND THE FOCUS ON PATIENTS WITH CHRONIC ILLNESS MAY EXPLAIN THE NEGATIVE OBSERVATIONS IN LIGHT OF PAST POSITIVE EVIDENCE REGARDING YOGA THERAPY. 2014 5 918 30 EFFECTIVENESS OF TRAINING PROGRAM COMBINING CHAKRAYOGA AND MEDITATION. BACKGROUND THIS STUDY WAS DESIGNED TO EXAMINE THE EFFECTIVENESS OF PROGRAM COMBINING CHAKRAYOGA AND MEDITATION ON THE PHYSICAL HEALTH AND DISEASE-RELATED FACTORS AND PSYCHOLOGICAL FACTORS OF PEOPLE. METHODS NINETY-SEVEN SUBJECTS (32-83 YEARS OLD) WHO HAD FREE FROM PRIOR EXPERIENCES IN MEDITATION PROGRAMS OR CHAKRAYOGA TRAINING COURSES WERE ASSIGNED TO EITHER THE EXPERIMENTAL GROUP (EXP) (45 SUBJECTS; 13 MALE SUBJECTS AND 32 FEMALE SUBJECTS; AVERAGE AGE OF 60.67 YEARS, SD=11.09 YEARS) OR THE CONTROL GROUP (CONT) OF REMAINING SUBJECTS (52 SUBJECTS; 14 MALE SUBJECTS AND 38 FEMALE SUBJECTS; AVERAGE AGE OF 61.58 YEARS, SD=9.70 YEARS). SUBJECTS IN THE EXP PARTICIPATED IN THE CHAKRAYOGA MEDITATION PROGRAM FOR TWICE A WEEK FOR 2 H DURING 6 WEEKS IN EACH SESSION CONSISTED OF 1 H OF CHAKRAYOGA AND 1 H OF MEDITATION. THE MEASUREMENTS IN THIS STUDY INCLUDED THE MINDFULNESS, STRESS RESPONSE, SUBJECTIVE QUALITY OF LIFE, MEDICAL SYMPTOM CHECKLIST, DIFFICULTY IN EMOTIONAL REGULATION AND OBJECTIVE OF LIFE AND SENSE OF CONTROL. RESULTS RESULTS REVEALED THAT PARTICIPANTS IN THE EXP REPORTED SIGNIFICANTLY MORE RELIEF OF MINDFULNESS, STRESS RESPONSE, SUBJECTIVE QUALITY OF LIFE AND MEDICAL SYMPTOM CHECKLIST THAN THOSE IN THE CONT. CONCLUSIONS THESE FINDINGS PROVIDE EVIDENCE THAT THE CHAKRAYOGA MEDITATION PROGRAM CAN HELP RELIEVE THE PHYSICAL HEALTH AND DISEASE-RELATED FACTORS AND PSYCHOLOGICAL FACTORS. 2019 6 2115 30 THE EFFECT OF YOGA ON THE QUALITY OF LIFE IN THE CHILDREN AND ADOLESCENTS WITH HAEMOPHILIA. THE PROBLEMS CAUSED BY HAEMOPHILIA LEAD TO IMPAIRMENTS OF THE QUALITY OF LIFE IN PATIENTS WITH HAEMOPHILIA. THIS STUDY AIMED TO INVESTIGATE THE EFFECTS OF YOGA ON QUALITY OF LIFE IN THE CHILDREN AND ADOLESCENTS WITH HAEMOPHILIA IN SHIRAZ, IRAN. THIS SEMI-EXPERIMENTAL STUDY WITH PRE- AND POST-TEST DESIGN WAS PERFORMED ON 27 BOYS BETWEEN 8 AND 16 YEARS OLD WHO SUFFERED FROM HAEMOPHILIA. THE PATIENTS WERE DIVIDED INTO TWO GROUPS. THE NUMBER OF BLEEDINGS, ABSENCES FROM SCHOOL, AND REFERRALS TO THE CLINIC WAS EVALUATED. THE DEMOGRAPHIC DATA WERE COLLECTED THROUGH INTERVIEWS AND USING THE PATIENTS' RECORDS IN THE HAEMOPHILIA CENTER. BESIDES, THE QUALITY OF LIFE WAS ASSESSED THROUGH THE HAEMO-QOL QUESTIONNAIRE. THEN, THE YOGA INTERVENTION WAS PERFORMED FOR 14 WEEKS AND THE DATA WERE COLLECTED IN THREE STAGES. THE COLLECTED DATA WERE ENTERED INTO THE SPSS STATISTICAL SOFTWARE, VERSION 18 AND WERE ANALYZED USING NON-PARAMETRIC FRIEDMAN TEST. AFTER THE INTERVENTION, SIGNIFICANT DIFFERENCES WERE OBSERVED IN THE MEAN SCORES OF QUALITY OF LIFE DIMENSIONS AND THE NUMBER OF BLEEDINGS, SCHOOL ABSENCES, AND REFERRALS TO THE HAEMOPHILIA CLINIC (P<0.001). THUS, YOGA MAY IMPROVE THE HAEMOPHILIA CHILDREN'S AND ADOLESCENTS' PERCEPTION OF QUALITY OF LIFE WITHOUT THE RISK OF INJURY. THIS INTERVENTION ALSO SEEMED TO BE EFFECTIVE IN REDUCING THE NUMBER OF BLEEDINGS, REFERRALS TO THE HAEMOPHILIA CLINIC, AND ABSENCES FROM SCHOOL. 2015 7 956 28 EFFECTS OF A PRENATAL YOGA PROGRAMME ON THE DISCOMFORTS OF PREGNANCY AND MATERNAL CHILDBIRTH SELF-EFFICACY IN TAIWAN. OBJECTIVE: TO EVALUATE A YOGA PROGRAMME PROVIDED TO PRIMIGRAVIDAS IN THE THIRD TRIMESTER OF PREGNANCY WITH THE AIM OF DECREASING THE DISCOMFORTS ASSOCIATED WITH PREGNANCY AND INCREASING CHILDBIRTH SELF-EFFICACY. DESIGN: NON-RANDOMISED CONTROLLED EXPERIMENTAL STUDY. SETTING: A HOSPITAL IN NORTHERN TAIWAN. PARTICIPANTS: THE TARGET POPULATION WAS PRIMIGRAVIDAS AT 26-28 WEEKS OF GESTATION (NO HIGH-RISK PREGNANCIES) WHO HAD NOT ENGAGED IN REGULAR EXERCISE OR YOGA FOR AT LEAST ONE YEAR. THE STUDY INCLUDED 88 INDIVIDUALS; 43 IN THE CONTROL GROUP AND 45 IN THE EXPERIMENTAL GROUP WHO TOOK PART IN THE PRENATAL YOGA PROGRAMME. INTERVENTION: THE DURATION OF THE PRENATAL YOGA PROGRAMME WAS 12-14 WEEKS, WITH AT LEAST THREE SESSIONS PER WEEK. EACH WORKOUT LASTED FOR 30 MINUTES. MEASUREMENTS AND FINDINGS: WOMEN WHO TOOK PART IN THE PRENATAL YOGA PROGRAMME REPORTED SIGNIFICANTLY FEWER PREGNANCY DISCOMFORTS THAN THE CONTROL GROUP (38.28 VS 43.26, Z=-2.58, P=0.01) AT 38-40 WEEKS OF GESTATION. THE SUBJECTS WHO PARTICIPATED IN THE YOGA PROGRAMME EXHIBITED HIGHER OUTCOME AND SELF-EFFICACY EXPECTANCIES DURING THE ACTIVE STAGE OF LABOUR (104.13 VS 83.53, T=3.24, P=0.002; 99.26 VS 77.70, T=3.99, P 4 WK PARTICIPATED IN AN 8-WK MBY INTERVENTION, 1X/WK FOR 45 MIN. PARTICIPATION, SELF-EFFICACY, AND HEART RATE VARIABILITY (24 HR) WERE COLLECTED BEFORE, AFTER, AND 3 MO AFTER THE INTERVENTION. HEART RATE VARIABILITY WAS ALSO MEASURED DURING EACH SESSION. RESULTS: TRENDS OF INCREASED SELF-EFFICACY IN ACADEMIC, SOCIAL, AND EMOTIONAL DOMAINS WERE FOUND AFTER MBY AND MAINTAINED AT 3-MO FOLLOW-UP. TRENDS OF INCREASING HEART RATE VARIABILITY WERE ALSO FOUND PRE- TO POSTINTERVENTION AND WITHIN THE EIGHT MBY SESSIONS. CONCLUSION: PRELIMINARY RESULTS REVEAL POSITIVE TRENDS AFTER A NOVEL, SAFE INTERVENTION FOR YOUTH WITH PERSISTENT CONCUSSION SYMPTOMS AND THE VALUE OF EXPLORING BOTH OCCUPATION-BASED AND NEUROPHYSIOLOGICAL MEASURES. FUTURE RESEARCH WITH A LARGER SAMPLE AND CONTROL GROUP IS WARRANTED. 2019 9 1657 22 MUSCULOSKELETAL PAIN AND INTEREST IN MEDITATION AND YOGA IN HOME HEALTH AIDES: EVIDENCE FROM THE HOME HEALTH OCCUPATIONS MUSCULOSKELETAL EXAMINATIONS (HHOME) STUDY. HOME HEALTHCARE AIDES (HHAS) ARE A GROWING U.S. WORKFORCE HIGHLY SUSCEPTIBLE TO WORKPLACE STRESSORS AND MUSCULOSKELETAL PAIN. IN THE PRESENT STUDY WE: 1) EXAMINE THE ASSOCIATION OF MUSCULOSKELETAL PAIN TO LIFE SATISFACTION AND EMOTIONAL EXHAUSTION; AND 2) CHARACTERIZE INTEREST IN MEDITATION AND YOGA IN A SAMPLE OF HHAS. A NONPROBABILISTIC SAMPLE OF HHAS EMPLOYED AT HOME HEALTHCARE AGENCIES IN FLORIDA, MASSACHUSETTS, AND OREGON (N = 285 TOTAL) COMPLETED A SELF-ADMINISTERED QUESTIONNAIRE WITH STANDARD SURVEY MEASURES ON MUSCULOSKELETAL PAIN LOCATION, DURATION, AND SEVERITY; LIFE SATISFACTION; EMOTIONAL EXHAUSTION; AND INTEREST IN MEDITATION TECHNIQUES AND YOGA. AMONG HHAS RESPONDING, 48.4% REPORTED PAIN IN THE LAST 7 DAYS AND 46.6% REPORTED PAIN IN THE LAST 3 MONTHS. HOME HEALTHCARE AIDES WHO REPORTED CURRENT PAIN AND CHRONIC PAIN HAD A SIGNIFICANT (P < .05) DECREASE IN SATISFACTION WITH LIFE SCORE AND A SIGNIFICANT INCREASE IN EMOTIONAL EXHAUSTION SCORE. THE MAJORITY OF HHAS REPORTED AN INTEREST IN LEARNING ABOUT THE BENEFITS (65.6%) AND PRACTICE (66.4%) OF MEDITATION AND A WILLINGNESS TO PARTICIPATE IN A YOGA CLASS (59.2%) OR STRESS MANAGEMENT MEETING (59.1%). THE HHAS REPORTED BOTH ACUTE AND CHRONIC MUSCULOSKELETAL PAIN THAT WAS CORRELATED WITH LOWER LIFE SATISFACTION AND GREATER EMOTIONAL EXHAUSTION. MORE EFFORTS ARE NEEDED TO REDUCE THE SOURCES OF INJURY AND EMOTIONAL EXHAUSTION. 2018 10 2747 27 YOGA PRACTICE IN DIABETES IMPROVES PHYSICAL AND PSYCHOLOGICAL OUTCOMES. BACKGROUND: THE AIM OF THIS STUDY WAS TO EXAMINE THE EFFECT OF YOGA PRACTICE ON CLINICAL AND PSYCHOLOGICAL OUTCOMES IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS (T2DM). METHODS: IN A 40-DAY YOGA CAMP AT THE INSTITUTE OF YOGA AND CONSCIOUSNESS, AMBULATORY SUBJECTS WITH T2DM NOT HAVING SIGNIFICANT COMPLICATIONS (N = 35) PARTICIPATED IN A 40-DAY YOGA CAMP, WHERE YOGIC PRACTICES WERE OVERSEEN BY TRAINED YOGA TEACHERS. CLINICAL, BIOCHEMICAL, AND PSYCHOLOGICAL WELL-BEING WERE STUDIED AT BASELINE AND AT THE END OF THE CAMP. RESULTS: AT THE END OF THE STUDY, THERE WAS A REDUCTION OF BODY MASS INDEX (BMI) (26.514 +/- 3.355 TO 25.771 +/- 3.40; P < 0.001) AND ANXIETY (6.20 +/- 3.72 TO 4.29 +/- 4.46; P < 0.05) AND AN IMPROVEMENT IN TOTAL GENERAL WELL-BEING (48.6 +/- 11.13 TO 52.66 +/- 52.66 +/- 12.87; P < 0.05). CONCLUSIONS: PARTICIPATION OF SUBJECTS WITH T2DM IN YOGA PRACTICE FOR 40 DAYS RESULTED IN REDUCED BMI, IMPROVED WELL-BEING, AND REDUCED ANXIETY. 2009 11 1277 27 FUNCTIONAL STATUS IN ADHESIVE CAPSULITIS - YOGA VS. PHYSIOTHERAPY: A QUASI EXPERIMENTAL STUDY. OBJECTIVES: ADHESIVE CAPSULITIS RESULTS IN A MULTIDIMENSIONAL DISABILITY WHICH DEMANDS A POLYGONAL APPROACH. ALTHOUGH PHYSIOTHERAPY PROVES AN ESSENTIAL FOR A COMPLETE AND COMPREHENSIVE RECOVERY IN ADHESIVE CAPSULITIS, EVIDENCE ALSO SUGGEST THE ROLE OF YOGA IN THE MANAGEMENT, HENCE THIS STUDY INVESTIGATE THEIR EFFECTIVENESS. METHODS: THIS IS A QUASI-RANDOMISED CONTROL STUDY. A PRE-DIAGNOSED SUBACUTE AND CHRONIC ADHESIVE CAPSULITIS OF SHOULDER, BETWEEN THE AGE GROUP OF 35-60 YEARS OF BOTH GENDERS OF TOTAL 40 PARTICIPANTS WERE RANDOMLY DIVIDED INTO GROUP 'A' (YOGASANA) AND GROUP 'B' (PHYSIOTHERAPY). THE PARAMETERS OF PAIN, JOINT MOBILITY AND FUNCTIONAL DISABILITIES WERE MEASURED AT THE BASELINE AND AFTER FOUR-WEEKS. RESULTS: THE MEAN AGE OF GROUP 'A' WAS 45.4 +/- 7.78 YEARS WHEREAS 50.05 +/- 5.98 YEARS WAS IN GROUP 'B'. INTRAGROUP ANALYSIS FOR BOTH THE GROUPS SHOWED STATISTICALLY SIGNIFICANT IMPROVEMENT IN ALL THE STUDY VARIABLES. WHEREAS IN INTERGROUP ANALYSIS YOGASANA WAS FOUND TO BE STATISTICALLY SIGNIFICANT IN IMPROVING SHOULDER ABDUCTION MOBILITY, P=0.03, EFFECT SIZE R=0.35 AND ALSO IN SHOULDER FLEXION (P=0.15, R=0.23) AND SHOULDER INTERNAL ROTATION (P=0.07, R=0.3), THOUGH STATISTICALLY NOT SIGNIFICANT, IN VIEW OF SMALL EFFECT SIZE RESPONSE. CONCLUSIONS: BOTH TECHNIQUES IMPROVED THE FUNCTIONAL STATUS IN ADHESIVE CAPSULITIS, HOWEVER ADDITIONAL EFFECTS ON JOINT MOBILITY WAS DEMONSTRATED BY YOGASANA. 2020 12 2771 16 YOGA REDUCES SYMPTOMS OF DISTRESS IN TSUNAMI SURVIVORS IN THE ANDAMAN ISLANDS. A MONTH AFTER THE DECEMBER 2004 TSUNAMI THE EFFECT OF A 1 WEEK YOGA PROGRAM WAS EVALUATED ON SELF RATED FEAR, ANXIETY, SADNESS AND DISTURBED SLEEP IN 47 SURVIVORS IN THE ANDAMAN ISLANDS. POLYGRAPH RECORDINGS OF THE HEART RATE, BREATH RATE AND SKIN RESISTANCE WERE ALSO MADE. AMONG THE 47 PEOPLE, 31 WERE SETTLERS FROM THE MAINLAND (I.E. INDIA, ML GROUP) AND 16 WERE ENDOGENOUS PEOPLE (EP GROUP). THERE WAS A SIGNIFICANT DECREASE IN SELF RATED FEAR, ANXIETY, SADNESS AND DISTURBED SLEEP IN BOTH GROUPS, AND IN THE HEART AND BREATH RATE IN THE ML GROUP, AND IN THE BREATH RATE ALONE IN THE EP GROUP, FOLLOWING YOGA (P < 0.05, T-TEST). THIS SUGGESTS THAT YOGA PRACTICE MAY BE USEFUL IN THE MANAGEMENT OF STRESS FOLLOWING A NATURAL DISASTER IN PEOPLE WITH WIDELY DIFFERING SOCIAL, CULTURAL AND SPIRITUAL BELIEFS. 2007 13 1517 29 IS YOGA ASSOCIATED WITH IMPROVED SLEEP AMONGST BREAST CANCER SURVIVORS? BACKGROUND: BREAST CANCER SURVIVORS MAY EXPERIENCE SLEEP DISTURBANCES THAT CAN AFFECT THEIR PHYSICAL AND MENTAL WELL-BEING. WE SOUGHT TO DETERMINE THE ASSOCIATION, IF ANY, BETWEEN YOGA AND SLEEP AMONG BREAST CANCER SURVIVORS IN A POPULATION-BASED COHORT. METHODS: THE NATIONAL HEALTH INTERVIEW SURVEY IS DESIGNED TO BE REPRESENTATIVE OF THE US CIVILIAN NON-INSTITUTIONALIZED POPULATION. WE EVALUATED BREAST CANCER SURVIVORS IN THE 2017 COHORT TO DETERMINE THE ASSOCIATION BETWEEN YOGA AND SELF-REPORTED QUALITY OF SLEEP. RESULTS: OF THE 25,905 PEOPLE SURVEYED, REPRESENTING 238,738,039 IN THE POPULATION, 1.59% REPORTED A PREVIOUS HISTORY OF BREAST CANCER. BREAST CANCER SURVIVORS WERE LESS LIKELY TO REPORT HAVING PRACTICED YOGA IN THE PRECEDING 12 MONTHS, COMPARED TO THOSE WITHOUT A HISTORY OF BREAST CANCER (9.98% VS 13.78%, P = .011). IN ADDITION, THEY WERE MORE LIKELY TO REPORT HAVING HAD TROUBLE FALLING ASLEEP (44.64% VS 36.32%, P = .002), STAYING ASLEEP (53.72% VS 39.43%, P < .001), AND USING SLEEP MEDICATION ON AT LEAST 1 DAY WITHIN THE PREVIOUS WEEK (23.80% VS 13.49%, P < .001) THAN THOSE WITHOUT BREAST CANCER. AMONG BREAST CANCER SURVIVORS, THERE WERE NO SIGNIFICANT DIFFERENCES IN DIFFICULTY FALLING ASLEEP (39.16% VS 44.98%, P = .482), DIFFICULTY STAYING ASLEEP (61.17% VS 52.70%, P = .305), AND NEEDING SLEEP MEDICATION (19.03% VS 24.53%, P = .395) BETWEEN THOSE WHO PRACTICED YOGA AND THOSE WHO DID NOT. CONTROLLING FOR SOCIODEMOGRAPHIC FACTORS, THERE REMAINED NO ASSOCIATION BETWEEN YOGA AND DIFFICULTY FALLING OR STAYING ASLEEP AMONG BREAST CANCER SURVIVORS. CONCLUSION: THERE IS NO DIRECT ASSOCIATION BETWEEN YOGA AND SLEEP QUALITY IN BREAST CANCER SURVIVORS. 2022 14 2160 27 THE EFFECTS OF WEIGHT BEARING YOGA TRAINING ON THE BONE RESORPTION MARKERS OF THE POSTMENOPAUSAL WOMEN. THIS STUDY WAS A PRELIMINARY REPORT TO INVESTIGATE THE EFFECTS OF THE WEIGHT BEARING YOGA TRAINING ON BOTH BONE RESORPTION MARKER AND THE QUALITY OF LIFE OF THE POSTMENOPAUSAL WOMEN. THE SAMPLES WERE RECRUITED BY THE PURPOSIVE SAMPLING FROM THE FEMALE CHULALONGKORN UNIVERSITY STAFF AGED BETWEEN 50-60 YEARS. THE SUBJECTS WERE DIVIDED INTO TWO GROUPS: EXPERIMENTAL GROUP AND CONTROL GROUP. THE BASELINE DEMOGRAPHIC DATA, THE BONE RESORPTION MARKER (BETA-CROSSLAPS), THE BONE FORMATION MARKER (P1NP) AND QUALITY OF LIFE (SF-36) DATA WERE COLLECTED. THE EXPERIMENTAL GROUP ATTENDED THE 12-WEEK WEIGHT-BEARING YOGA TRAINING 3 DAYS A WEEK, 50 MINUTES A DAY WHILE THE CONTROL GROUP LIVED THEIR NORMAL LIVES. AFTER 12TH WEEK, THE DATA COLLECTIONS WERE REPEATED IN BOTH GROUPS. THE EXPERIMENTAL GROUP (19 SUBJECTS, THE MEAN AGE 54.320 YRS) AND THE CONTROL GROUP (14 SUBJECTS, THE MEAN AGE 54.430 YRS) WERE RECRUITED. THE MEAN ULTRASOUND BMD OF BOTH HEELS IN BOTH GROUPS SHOWED NO OSTEOPENIA OR OSTEOPOROSIS. AFTER THE 12-WEEK TRAINING, THE MEAN BONE RESORPTION MARKER (BETA-CROSSLAPS) OF THE EXPERIMENTAL GROUP REDUCED FROM 0.464 TO 0.339 NG/ML (-26.939%) WHEREAS THE CONTROL GROUP REDUCED FROM 0.389 TO 0.386 NG/ML (-0.771%). THERE WAS A SIGNIFICANT DIFFERENCE (P < 0.05). THE MEAN OF THE BONE FORMATION MARKERS (PINP) IN THE EXPERIMENTAL GROUP REDUCED FROM 55.393 TO 42.401 NG/ML (-23.454%) AND THE BONE FORMATION MARKERS (PINP) IN THE CONTROL GROUP REDUCED FROM 61.903 TO 44.832 NG/ML (-27.577%). IN THE AREA OF THE LIFE QUALITY MEASUREMENT OF BOTH GROUPS, THE DATA OBTAINED FROM THE MEDICAL OUTCOMES STUDY SHORT-FORM SURVEY (SF-36) SHOWED THAT THERE WERE SIGNIFICANT DIFFERENCES AT 0.05 LEVELS FOR THE PHYSICAL FUNCTIONING, BODILY PAIN, GENERAL HEALTH, AND VITALITY. THE VARIANCE OF PERCENTAGE CHANGE VALUE OF THE EXPERIMENTAL GROUP INCREASED TO +25.299, +16.565, +15.309, AND +21.056. THE VARIANCE OF PERCENTAGE CHANGE VALUE OF THE CONTROL GROUP INCREASED TO +12.946, -1.221, -9.303 AND +2.291. THE WEIGH-BEARING YOGA TRAINING HAD A POSITIVE EFFECT ON BONE BY SLOWING DOWN BONE RESORPTION WHICH WAS A VERY ESSENTIAL INDICATOR FOR HUMAN HEALTH BECAUSE IT REDUCED THE OSTEOPOROSIS RISKS IN THE POSTMENOPAUSAL WOMEN. ADDITIONALLY, YOGA TRAINING PROMOTED BETTER QUALITY OF LIFE. 2009 15 1468 28 INNER ENGINEERING PRACTICES AND ADVANCED 4-DAY ISHA YOGA RETREAT ARE ASSOCIATED WITH CANNABIMIMETIC EFFECTS WITH INCREASED ENDOCANNABINOIDS AND SHORT-TERM AND SUSTAINED IMPROVEMENT IN MENTAL HEALTH: A PROSPECTIVE OBSERVATIONAL STUDY OF MEDITATORS. BACKGROUND: ANXIETY AND DEPRESSION ARE COMMON IN THE MODERN WORLD, AND THERE IS GROWING DEMAND FOR ALTERNATIVE THERAPIES SUCH AS MEDITATION. MEDITATION CAN DECREASE PERCEIVED STRESS AND INCREASE GENERAL WELL-BEING, ALTHOUGH THE PHYSIOLOGICAL MECHANISM IS NOT WELL-CHARACTERIZED. ENDOCANNABINOIDS (ECBS), LIPID MEDIATORS ASSOCIATED WITH ENHANCED MOOD AND REDUCED ANXIETY/DEPRESSION, HAVE NOT BEEN PREVIOUSLY STUDIED AS BIOMARKERS OF MEDITATION EFFECTS. OUR AIM WAS TO ASSESS BIOMARKERS (ECBS AND BRAIN-DERIVED NEUROTROPHIC FACTOR [BDNF]) AND PSYCHOLOGICAL PARAMETERS AFTER A MEDITATION RETREAT. METHODS: THIS WAS AN OBSERVATIONAL PILOT STUDY OF ADULTS BEFORE AND AFTER THE 4-DAY ISHA YOGA BHAVA SPANDANA PROGRAM RETREAT. PARTICIPANTS COMPLETED ONLINE SURVEYS (BEFORE AND AFTER RETREAT, AND 1 MONTH LATER) TO ASSESS ANXIETY, DEPRESSION, FOCUS, WELL-BEING, AND HAPPINESS THROUGH VALIDATED PSYCHOLOGICAL SCALES. VOLUNTARY BLOOD SAMPLING FOR BIOMARKER STUDIES WAS DONE BEFORE AND WITHIN A DAY AFTER THE RETREAT. THE BIOMARKERS ANANDAMIDE, 2-ARACHIDONOYLGLYCEROL (2-AG), 1-ARACHIDONOYLGLYCEROL (1-AG), DOCOSATETRAENOYLETHANOLAMIDE (DEA), OLEOYLETHANOLAMIDE (OLA), AND BDNF WERE EVALUATED. PRIMARY OUTCOMES WERE CHANGES IN PSYCHOLOGICAL SCALES, AS WELL AS CHANGES IN ECBS AND BDNF. RESULTS: DEPRESSION AND ANXIETY SCORES DECREASED WHILE FOCUS, HAPPINESS, AND POSITIVE WELL-BEING SCORES INCREASED IMMEDIATELY AFTER RETREAT FROM THEIR BASELINE VALUES (P < 0.001). ALL IMPROVEMENTS WERE SUSTAINED 1 MONTH AFTER BSP. ALL MAJOR ECBS INCLUDING ANANDAMIDE, 2-AG, 1-AG, DEA, AND BDNF INCREASED AFTER MEDITATION BY > 70% (P < 0.001). INCREASES OF >/=20% IN ANANDAMIDE, 2-AG, 1-AG, AND TOTAL AG LEVELS AFTER MEDITATION FROM THE BASELINE HAD WEAK CORRELATIONS WITH CHANGES IN HAPPINESS AND WELL-BEING. CONCLUSIONS: A SHORT MEDITATION EXPERIENCE IMPROVED FOCUS, HAPPINESS, AND POSITIVE WELL-BEING AND REDUCED DEPRESSION AND ANXIETY IN PARTICIPANTS FOR AT LEAST 1 MONTH. PARTICIPANTS HAD INCREASED BLOOD ECBS AND BDNF, SUGGESTING A ROLE FOR THESE BIOMARKERS IN THE UNDERLYING MECHANISM OF MEDITATION. MEDITATION IS A SIMPLE, ORGANIC, AND EFFECTIVE WAY TO IMPROVE WELL-BEING AND REDUCE DEPRESSION AND ANXIETY. 2020 16 712 29 EFFECT OF INTEGRATED YOGA ON ANTI-PSYCHOTIC INDUCED SIDE EFFECTS AND COGNITIVE FUNCTIONS IN PATIENTS SUFFERING FROM SCHIZOPHRENIA. BACKGROUND TWENTY ONE (12 FEMALES) SUBJECTS, DIAGNOSED WITH SCHIZOPHRENIA BY A PSYCHIATRIST USING ICD-10, IN THE AGES 52.87 + 9.5YEARS AND SUFFERING SINCE 24.0 +/- 3.05YEARS WERE RECRUITED INTO THE STUDY FROM A SCHIZOPHRENIA REHABILITATION CENTER IN BENGALURU. METHODS ALL SUBJECTS WERE TAKING ANTI-PSYCHOTIC MEDICATIONS AND WERE IN STABLE STATE FOR MORE THAN A MONTH. PSYCHIATRIC MEDICATIONS WERE KEPT CONSTANT DURING THE STUDY PERIOD. ASSESSMENTS WERE DONE AT THREE POINTS OF TIME: (1) BASELINE, (2) AFTER ONE MONTH OF USUAL ROUTINE (PRE) AND (3) AFTER FIVE MONTHS OF VALIDATED INTEGRATED YOGA (IY) INTERVENTION (POST). VALIDATED 1H YOGA MODULE (CONSISTING OF ASANAS, PRANAYAMA, RELAXATION TECHNIQUES AND CHANTINGS) WAS PRACTICED FOR 5MONTHS, FIVE SESSIONS PER WEEK. ANTIPSYCHOTIC-INDUCED SIDE EFFECTS WERE ASSESSED USING SIMPSON ANGUS SCALE (SAS) AND UDVALG FOR KLINISKE UNDERSOGELSER (UKU) SIDE EFFECT RATING SCALE. COGNITIVE FUNCTIONS (USING TRAIL MAKING TEST A AND B), CLINICAL SYMPTOMS AND ANTHROPOMETRY WERE ASSESSED AS SECONDARY VARIABLES. COMPARISONS BETWEEN "PRE" AND "POST" DATA WAS DONE USING PAIRED SAMPLES T-TESTS AFTER SUBTRACTING BASELINE SCORES FROM THEM RESPECTIVELY. RESULTS AT THE END OF FIVE MONTHS, SIGNIFICANT REDUCTION IN DRUG-INDUCED PARKINSONIAN SYMPTOMS (SAS SCORE; P=0.001) AND 38 ITEMS OF UKU SCALE WAS OBSERVED ALONG WITH SIGNIFICANT IMPROVEMENT IN PROCESSING SPEED, EXECUTIVE FUNCTIONS AND NEGATIVE SYMPTOMS OF SCHIZOPHRENIA PATIENTS. NO SIDE EFFECTS OF YOGA WERE REPORTED. CONCLUSIONS THE PRESENT STUDY PROVIDES PRELIMINARY EVIDENCE FOR USEFULNESS OF INTEGRATED YOGA INTERVENTION IN MANAGING ANTI-PSYCHOTIC-INDUCED SIDE EFFECTS. 2018 17 2049 33 THE APPLICATION OF "UPPER-BODY YOGA" IN ELDERLY PATIENTS WITH ACUTE HIP FRACTURE: A PROSPECTIVE, RANDOMIZED, AND SINGLE-BLIND STUDY. PURPOSES: HIP FRACTURE LEADS TO DECREASED ACTIVITY AND AN INCREASED RISK OF PULMONARY COMPLICATIONS. THE MAIN PURPOSE OF THIS STUDY WAS TO OBSERVE THE LUNG CAPACITY, COUGH CAPACITY OF THE ELDERLY PATIENT WITH ACUTE HIP FRACTURE, AND ASSESS THE EFFECTS AND THE FEASIBILITY OF USING A SPECIAL-DESIGNED "UPPER-BODY YOGA" TRAINING TO TREAT ELDERLY PATIENTS WITH HIP FRACTURE. METHODS: THIS WAS A PROSPECTIVE, RANDOMIZED, AND SINGLE-BLIND STUDY. EIGHTY-FOUR SUBJECTS AGED OVER 65 YEARS WERE RANDOMLY DIVIDED INTO EITHER A CONTROL GROUP OR A YOGA GROUP TO UNDERGO AN ABDOMINAL BREATHING PROGRAM OR AN "UPPER-BODY YOGA" PROGRAM UNTIL 4 WEEKS AFTER SURGERY. THE PRIMARY OUTCOMES WERE FORCED VITAL CAPACITY/PREDICTED VALUE (FVC%), PEAK COUGH FLOW (PCF), BARTHEL INDEX (BI), AND THE INCIDENCE OF PNEUMONIA. THE SECONDARY OUTCOMES WERE THE RATES OF RIGHT SKILLS AND INCLINATION. RESULTS: THIRTY-NINE SUBJECTS IN THE YOGA GROUP AND 40 SUBJECTS IN THE CONTROL GROUP COMPLETED THIS STUDY. AT THE END OF THE FIRST TRAINING WEEK, FVC% (74.14% +/- 13.11% VS. 70.87% +/- 10.46%, P = 0.231) SHOWED NO SIGNIFICANT DIFFERENCE BETWEEN THE TWO GROUPS, WHILE THE VALUE OF PCF (204.80 +/- 33.45 L/MIN VS. 189.06 +/- 34.80 L/MIN, P = 0.048) AND BI (38.59 +/- 8.66 VS. 33.00 +/- 9.32, P = 0.009) IN THE YOGA GROUP WAS HIGHER. AFTER 4 WEEKS OF TREATMENT, FVC%, PCF, AND BI WERE HIGHER IN THE YOGA GROUP (78.83% +/- 13.31 % VS. 72.20% +/- 10.53%, P = 0.016; 216.16 +/- 39.29 L/MIN VS. 194.95 +/- 31.14 L/MIN, P = 0.008; 70.77 +/- 10.23 VS. 65.75 +/- 11.30, P = 0.019). ONE IN THE CONTROL GROUP AND NOBODY IN THE YOGA GROUP WAS DIAGNOSED WITH PNEUMONIA. THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THE TWO GROUPS IN TERMS OF THE RATES OF RIGHT SKILLS, WHEREAS MORE ELDERLY PEOPLE PREFERRED THE TRAINING PROGRAM OF THE "UPPER-BODY YOGA." CONCLUSION: ELDERLY PATIENTS WITH ACUTE HIP FRACTURES ARE AT RISK OF IMPAIRED LUNG CAPACITY AND INADEQUATE COUGH. "UPPER-BODY YOGA" TRAINING MAY IMPROVE THE QUALITY OF DAILY LIFE, VITAL CAPACITY, AND COUGH FLOW IN ELDERLY PATIENTS, MAKING IT A BETTER CHOICE FOR BEDRIDDEN PATIENTS WITH HIP FRACTURE. 2019 18 2595 25 YOGA FOR MILITARY SERVICE PERSONNEL WITH PTSD: A SINGLE ARM STUDY. THIS STUDY EVALUATED THE EFFECTS OF YOGA ON POSTTRAUMATIC STRESS DISORDER (PTSD) SYMPTOMS, RESILIENCE, AND MINDFULNESS IN MILITARY PERSONNEL. PARTICIPANTS COMPLETING THE YOGA INTERVENTION WERE 12 CURRENT OR FORMER MILITARY PERSONNEL WHO MET THE DIAGNOSTIC AND STATISTICAL MANUAL FOR MENTAL DISORDERS-FOURTH EDITION-TEXT REVISION (DSM-IV-TR) DIAGNOSTIC CRITERIA FOR PTSD. RESULTS WERE ALSO BENCHMARKED AGAINST OTHER MILITARY INTERVENTION STUDIES OF PTSD USING THE CLINICIAN ADMINISTERED PTSD SCALE (CAPS; BLAKE ET AL., 2000) AS AN OUTCOME MEASURE. RESULTS OF WITHIN-SUBJECT ANALYSES SUPPORTED THE STUDY'S PRIMARY HYPOTHESIS THAT YOGA WOULD REDUCE PTSD SYMPTOMS (D = 0.768; T = 2.822; P = .009) BUT DID NOT SUPPORT THE HYPOTHESIS THAT YOGA WOULD SIGNIFICANTLY INCREASE MINDFULNESS (D = 0.392; T = -0.9500; P = .181) AND RESILIENCE (D = 0.270; T = -1.220; P = .124) IN THIS POPULATION. BENCHMARKING RESULTS INDICATED THAT, AS COMPARED WITH THE AGGREGATED TREATMENT BENCHMARK (D = 1.074) OBTAINED FROM PUBLISHED CLINICAL TRIALS, THE CURRENT STUDY'S TREATMENT EFFECT (D = 0.768) WAS VISIBLY LOWER, AND COMPARED WITH THE WAITLIST CONTROL BENCHMARK (D = 0.156), THE TREATMENT EFFECT IN THE CURRENT STUDY WAS VISIBLY HIGHER. 2015 19 1229 33 FEASIBILITY AND IMPACT OF AN 8-WEEK INTEGRATIVE YOGA PROGRAM IN PEOPLE WITH MODERATE MULTIPLE SCLEROSIS-RELATED DISABILITY: A PILOT STUDY. BACKGROUND: THIS PILOT STUDY DETERMINED THE FEASIBILITY OF A SPECIFICALLY DESIGNED 8-WEEK YOGA PROGRAM FOR PEOPLE WITH MODERATE MULTIPLE SCLEROSIS (MS)-RELATED DISABILITY. WE EXPLORED THE PROGRAM'S EFFECT ON QUALITY OF LIFE (QOL) AND PHYSICAL AND MENTAL PERFORMANCE. METHODS: WE USED A SINGLE-GROUP DESIGN WITH REPEATED MEASUREMENTS AT BASELINE, POSTINTERVENTION, AND 8-WEEK FOLLOW-UP. FEASIBILITY WAS EXAMINED THROUGH COST, RECRUITMENT, RETENTION, ATTENDANCE, AND SAFETY. OUTCOMES INCLUDED THE MULTIPLE SCLEROSIS QUALITY OF LIFE INVENTORY (MSQLI), 12-ITEM MULTIPLE SCLEROSIS WALKING SCALE (MSWS-12), TIMED 25-FOOT WALK TEST (T25FW), 6-MINUTE WALK TEST (6MWT), NINE-HOLE PEG TEST (NHPT), FIVE-TIMES SIT-TO-STAND TEST (FTSTS), MULTIDIRECTIONAL REACH TEST (MDRT), MAXIMUM EXPIRATORY PRESSURE, AND PACED AUDITORY SERIAL ADDITION TEST-3'' (PASAT-3''). RESULTS: FOURTEEN PARTICIPANTS COMPLETED THE STUDY. THE PROGRAM WAS FEASIBLE. THERE WERE SIGNIFICANT MAIN EFFECTS ON THE 36-ITEM SHORT FORM HEALTH STATUS SURVEY MENTAL COMPONENT SUMMARY (SF-36 MCS), MODIFIED FATIGUE IMPACT SCALE (MFIS), BLADDER CONTROL SCALE (BLCS), PERCEIVED DEFICITS QUESTIONNAIRE (PDQ), MENTAL HEALTH INVENTORY (MHI), MSWS-12, T25FW, NHPT, PASAT-3'', 6MWT, FTSTS, AND MDRT-BACK. IMPROVEMENTS WERE FOUND ON THE SF-36 MCS, MFIS, BLCS, PDQ, MHI, AND MSWS-12 BETWEEN BASELINE AND POSTINTERVENTION. THE EFFECT ON PDQ PERSISTED AT FOLLOW-UP. IMPROVEMENTS WERE FOUND ON THE T25FW, NHPT, 6MWT, FTSTS, AND MDRT-BACK BETWEEN BASELINE AND POSTINTERVENTION THAT PERSISTED AT FOLLOW-UP. THE PASAT-3'' DID NOT CHANGE BETWEEN BASELINE AND POSTINTERVENTION BUT DID BETWEEN POSTINTERVENTION AND FOLLOW-UP. CONCLUSIONS: THE YOGA PROGRAM WAS SAFE AND FEASIBLE. IMPROVEMENTS IN CERTAIN MEASURES OF QOL AND PERFORMANCE WERE SEEN AT POSTINTERVENTION AND FOLLOW-UP. 2017 20 2905 22 [LONG-TERM EFFECTS OF BREATHING EXERCISES AND YOGA IN PATIENTS WITH BRONCHIAL ASTHMA]. TO COMPARE THE EFFECTS OF BREATHING EXERCISES (BE) OR YOGA (Y) ON THE COURSE OF BRONCHIAL ASTHMA WE STUDIED 36 SUBJECTS WITH A MILD DISEASE. THE PATIENTS WERE RANDOMLY DIVIDED INTO 3 GROUPS. 2 OF THEM PARTICIPATED IN A 3 WEEKS TRAINING PROGRAM OF BE OR Y WHILE THE THIRD GROUP RESTED WITHOUT ANY ADDITIONAL TREATMENT (CONTROL GROUP, C). AT THE END OF THE TRAINING PERIOD THE PATIENTS WERE ASKED TO PRACTISE BE OR Y ON THEIR OWN. DRUG THERAPY AND LUNG FUNCTION PARAMETERS BEFORE AND AFTER A BETA 2-AGONIST METERED DOSE INHALER (ALBUTEROL, ALB) WERE RECORDED PRIOR TO THE TRAINING PROGRAM AND IN 4 WEEKS INTERVALS FOR 4 MONTHS THEREAFTER. THE RESPONSE TO THE BETA 2-AGONIST WAS DOCUMENTED CONTINUOUSLY IN 28 PATIENTS. THE MENTAL STATE OF THE PATIENTS WAS ELUCIDATED BY QUESTIONNAIRES.--PRIOR TO THE STUDY A SIGNIFICANT EFFECT OF INHALED ALB ON THE FEV1 WAS SHOWN WITHOUT ANY SIGNIFICANT BETWEEN GROUP DIFFERENCES. BOTH, BE AND Y, CAUSED A SIGNIFICANT AMELIORATION OF THE MENTAL STATE BUT ONLY THE BE INDUCED A SIGNIFICANT IMPROVEMENT OF LUNG FUNCTION PARAMETERS COMPARED TO THE INDIVIDUAL BASELINE VALUES. THE FEV1 INCREASED SIGNIFICANTLY BY 356.3 +/- 146.2 ML (P < 0.05) AND THE VC BY 225.0 +/- 65.5 ML (P < 0.01). THESE LONG-TERM CHANGES WERE NOT SIGNIFICANTLY DIFFERENT FROM THE ACTUAL RESPONSE TO ALB. BE DECREASED THE RV SIGNIFICANTLY BY 306.3 +/- 111.6 ML (P < 0.05), AN EFFECT SIGNIFICANTLY HIGHER COMPARED TO THE BETA 2-AGONIST (P < 0.01). BE IN COMBINATION WITH ALB CAUSED AN ADDITIVE EFFECT.(ABSTRACT TRUNCATED AT 250 WORDS) 1994